Skip to page content |

Tiscali Quicklinks. Please visit our Accessibility Page for a list of the Access Keys you can use to find your way around the site, skip directly to the main navigation, to the page content, or to more links within reference.

Advertisement starts



Advertisement ends

Content Starts Here


sickle-cell disease

encyclopaedia header
Encyclopaedia Search
Click a letter for the index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Or search the encyclopaedia:
 
 
 
all results tagged with the © symbol denotes content that is relevant to the national curriculum

Sickle-cell Disease


Hereditary chronic blood disorder common among people of black African descent; also found in the eastern Mediterranean, parts of the Gulf, and in northeastern India. It is characterized by distortion and fragility of the red blood cells, which are lost too rapidly from the circulation. This often results in anaemia.

People with this disease have abnormal red blood cells (sickle cells), containing defective haemoglobin. The presence of sickle cells in the blood is called sicklemia. The disease is caused by a recessive allele. Those with two copies of the allele suffer debilitating anaemia; those with a single copy paired with the normal allele, suffer with only mild anaemia and have a degree of protection against malaria because fewer normal red blood cells are available to the parasites for infection.

In the USA there were approximately 65,000 African-Americans suffering from sickle-cell disease in 1996; there were about 5,500 British sufferers. Worldwide, 100,000 babies are born with the disease annually. Those born in developing countries are unlikely to survive for long.

Bone marrow transplantation can provide a cure, but the risks (a fatality rate of 10% and a complications rate of 20%) are so great that it is only an option for the severely ill. US researchers announced in April 1995 that patients treated with a drug called hydroxyurea showed a reduction in the number of sickle cells. The drug works by reducing the amount of defective haemoglobin produced, and reviving the production of fetal haemoglobin. Fetal haemoglobin is not affected by sickling. Partial (40%) bone marrow transplants used during early 2001 in sickle-cell treatment trials in the USA also proved successful in combating the disease.

© Research Machines plc 2008. All rights reserved. Helicon Publishing is a division of Research Machines plc.


 
 

Advertisement starts



Advertisement ends


Rwanda Flag
Rwanda Flag Green symbolizes hopes of prosperity. Yellow stands for economic development and work. Blue represents peace and happiness. The sun represents light and enlightenment. Effective date: 31 December 2001. >>

Advertorial

AdvertorialFind out how to buy the things you've always wanted and sell the things you don't on ebay.

Advertisement starts



Advertisement ends

Page Footer


Access keys


You will need to use different key combinations in order to use access keys depending on your internet browser, find out which on our accessibility page.
  • (0) Navigate to Accessibility page.
  • (1) Navigate to Home page.
  • (2) Navigate to My email.
  • (3) Navigate to My Account.
  • (4) Navigate to Site Map page.
  • (5) Navigate to Contact us page.
  • (6) Navigate to Members channel.
  • (7) Navigate to Services channel.
  • (8) Navigate to News & Info channel.
  • (9) Navigate to Entertainment channel.
  • ([) Skip down to the Primary navigation block.
  • (]) Skip down to the more links within this section block.
  • (=) Bypass all navigation and jump to the content.